Clinical Trials

Blog Post

Do You Know ALS? Meet Tim.

By MDA Staff | May 26, 2019
Illustration of DNA
Blog Post

FDA Approves AveXis’ Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

By Jeanene Swanson | May 24, 2019
Blog Post

Do You Know ALS? Diagnosing the Disease is an Odyssey.

By Jeanene Swanson | May 21, 2019
Blog Post

Do You Know ALS? Read About the Latest Research.

By Jeanene Swanson | May 15, 2019
Blog Post

Do You Know ALS? Meet Sandy.

By MDA Staff | May 14, 2019
Blog Post

FDA Approves Jacobus Pharmaceuticals’ Ruzurgi for Treatment of Children with Lambert-Eaton Myasthenic Syndrome

By Jeanene Swanson | May 8, 2019
Blog Post

Progress in Motion: MDA’s 2019 Clinical & Scientific Conference Heralds New Directions for Neuromuscular Disease Treatment

By MDA Staff | May 3, 2019
Blog Post

Biogen Releases Letter to ALS Community

By MDA Staff | May 2, 2019
Blog Post

Clinical Trial Alert: PTC Therapeutics Seeks Participants for a Phase 3 DMD Study

By MDA Staff | April 24, 2019
Blog Post

Sarepta Therapeutics Announces Positive Interim Results from Study of Casimersen to Treat DMD Amenable to Exon 45 Skipping

By Jeanene Swanson | April 4, 2019